These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33105568)

  • 1. Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors.
    Rochow H; Jung M; Weickmann S; Ralla B; Stephan C; Elezkurtaj S; Kilic E; Zhao Z; Jung K; Fendler A; Franz A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer.
    Hansen EB; Fredsøe J; Okholm TLH; Ulhøi BP; Klingenberg S; Jensen JB; Kjems J; Bouchelouche K; Borre M; Damgaard CK; Pedersen JS; Kristensen LS; Sørensen KD
    Genome Med; 2022 Jan; 14(1):8. PubMed ID: 35078526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
    Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic Accuracy.
    Franz A; Ralla B; Weickmann S; Jung M; Rochow H; Stephan C; Erbersdobler A; Kilic E; Fendler A; Jung K
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality.
    Rochow H; Franz A; Jung M; Weickmann S; Ralla B; Kilic E; Stephan C; Fendler A; Jung K
    Theranostics; 2020; 10(20):9268-9279. PubMed ID: 32802191
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer.
    Shao N; Zhu Y; Wan FN; Ye DW
    Asian J Androl; 2019; 21(6):618-622. PubMed ID: 30860081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer.
    Zhong C; Wu K; Wang S; Long Z; Yang T; Zhong W; Tan X; Wang Z; Li C; Lu J; Mao X
    Cell Death Dis; 2021 Jul; 12(8):726. PubMed ID: 34294687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
    Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
    Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
    Zhao Y; Tao Z; Li L; Zheng J; Chen X
    BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
    Xing Q; Liu S; Luan J; Wang Y; Ma L
    Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.
    Yu L; Toriseva M; Tuomala M; Seikkula H; Elo T; Tuomela J; Kallajoki M; Mirtti T; Taimen P; Boström PJ; Alanen K; Nurmi M; Nees M; Härkönen P
    Int J Cancer; 2016 Jul; 139(1):140-52. PubMed ID: 26891277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.
    Liu B; Li X; Li J; Jin H; Jia H; Ge X
    Dis Markers; 2020; 2020():8860788. PubMed ID: 33101546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.
    Ning L; Long B; Zhang W; Yu M; Wang S; Cao D; Yang J; Shen K; Huang Y; Lang J
    Int J Oncol; 2018 Dec; 53(6):2637-2646. PubMed ID: 30272264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
    Kulda V; Topolcan O; Kucera R; Kripnerova M; Srbecka K; Hora M; Hes O; Klecka J; Babuska V; Rousarova M; Benson V; Pesta M
    Anticancer Res; 2016 Sep; 36(9):4787-93. PubMed ID: 27630329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.